These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16286242)

  • 21. Drosophila Dystrophin is required for integrity of the musculature.
    van der Plas MC; Pilgram GS; de Jong AW; Bansraj MR; Fradkin LG; Noordermeer JN
    Mech Dev; 2007 Aug; 124(7-8):617-30. PubMed ID: 17543506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
    Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
    Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer cachexia: mediators, signaling, and metabolic pathways.
    Fearon KC; Glass DJ; Guttridge DC
    Cell Metab; 2012 Aug; 16(2):153-66. PubMed ID: 22795476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms regulating skeletal muscle growth and atrophy.
    Schiaffino S; Dyar KA; Ciciliot S; Blaauw B; Sandri M
    FEBS J; 2013 Sep; 280(17):4294-314. PubMed ID: 23517348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The possible role of myostatin in skeletal muscle atrophy and cachexia.
    Jespersen J; Kjaer M; Schjerling P
    Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear and nuclear envelope localization of dystrophin Dp71 and dystrophin-associated proteins (DAPs) in the C2C12 muscle cells: DAPs nuclear localization is modulated during myogenesis.
    González-Ramírez R; Morales-Lázaro SL; Tapia-Ramírez V; Mornet D; Cisneros B
    J Cell Biochem; 2008 Oct; 105(3):735-45. PubMed ID: 18680104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two tales concerning skeletal muscle.
    Glass DJ
    J Clin Invest; 2007 Sep; 117(9):2388-91. PubMed ID: 17786235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice.
    Tian M; Asp ML; Nishijima Y; Belury MA
    Int J Oncol; 2011 Nov; 39(5):1321-6. PubMed ID: 21822537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knocking signalling out of the dystrophin complex.
    Bredt DS
    Nat Cell Biol; 1999 Aug; 1(4):E89-91. PubMed ID: 10559928
    [No Abstract]   [Full Text] [Related]  

  • 30. Powerful signals for weak muscles.
    Saini A; Faulkner S; Al-Shanti N; Stewart C
    Ageing Res Rev; 2009 Oct; 8(4):251-67. PubMed ID: 19716529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
    Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrophy and hypertrophy of skeletal muscles: structural and functional aspects.
    Boonyarom O; Inui K
    Acta Physiol (Oxf); 2006 Oct; 188(2):77-89. PubMed ID: 16948795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biology of the striated muscle dystrophin-glycoprotein complex.
    Ervasti JM; Sonnemann KJ
    Int Rev Cytol; 2008; 265():191-225. PubMed ID: 18275889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle.
    Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S
    J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy.
    Sartorelli V; Fulco M
    Sci STKE; 2004 Jul; 2004(244):re11. PubMed ID: 15292521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal-transduction networks and the regulation of muscle protein degradation.
    Szewczyk NJ; Jacobson LA
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1997-2011. PubMed ID: 16125109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of alpha-dystrobrevin in blood-tissue barriers: sub-cellular localisation and molecular characterisation in normal and dystrophic mice.
    Lien CF; Hazai D; Yeung D; Tan J; Füchtbauer EM; Jancsik V; Górecki DC
    Cell Tissue Res; 2007 Jan; 327(1):67-82. PubMed ID: 16868787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy.
    Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U
    Hum Mol Genet; 2006 Mar; 15(6):989-98. PubMed ID: 16476707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle wasting in cardiac cachexia.
    Strassburg S; Springer J; Anker SD
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1938-47. PubMed ID: 15927519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation of ERK and dystrophin S3059 protects against inflammation-associated C2C12 myotube atrophy.
    Swiderski K; Brock CJ; Trieu J; Chee A; Thakur SS; Baum DM; Gregorevic P; Murphy KT; Lynch GS
    Am J Physiol Cell Physiol; 2021 Jun; 320(6):C956-C965. PubMed ID: 33729835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.